Search
Innovative Drug Concept Continues to Strengthen, Lianhuan Pharmaceutical Records Six Board Rises in Eight Days
2025-07-16 /
Read about 0 minute
Author：小编
The National Healthcare Security Administration has recently unveiled the 11th batch of drug centralized procurement, clearly stating the principle of 'centralized procurement for non-new drugs, and exclusion of new drugs from centralized procurement'. Fifty-five types of clinically established 'old drugs' have been included in the centralized procurement scope, while innovative drugs remain unaffected by this initiative. Consequently, many related stocks have witnessed substantial gains.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
